About 342,000 results
Open links in new tab
Keytruda beaten by Summit’s bispecific in NSCLC - Yahoo Finance
Why Summit Therapeutics Rocketed Over 60% Today - Yahoo …
Why Summit Therapeutics Stock Is Soaring Again Today - Yahoo …
Despite Win Over Keytruda, Summit’s NSCLC Bispecific Still Has ...
Press Releases - Summit Therapeutics
WCLC: Summit trumpets data with Keytruda challenger
Summit Therapeutics’ stock surges as lung-cancer treatment vies …
Summit Therapeutics' stock surges as lung-cancer treatment vies …
Summit Therapeutics Secures $235 Million in Funding from …
Summit Therapeutics Announces Initial Indications for Clinical …